Own the gold standard ✨ in financial data & analytics
fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

Subscribe for $2
Overview
Profile

Organon & stock price, quote, forecast and news

OGN
US68622V1061
A3CPKP

Price

22.36 USD
Today +/-
+1.31 USD
Today %
+6.80 %
P

Organon & stock price

USD
%
Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the Organon & stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the Organon & stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the Organon & stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze Organon &'s market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

Organon & Stock Price History

DateOrganon & Price
8/23/202422.36 USD
8/22/202420.89 USD
8/21/202421.03 USD
8/20/202420.80 USD
8/19/202420.96 USD
8/16/202420.35 USD
8/15/202420.22 USD
8/14/202419.97 USD
8/13/202420.29 USD
8/12/202419.46 USD
8/9/202420.15 USD
8/8/202419.56 USD
8/7/202419.05 USD
8/6/202418.65 USD
8/5/202420.19 USD
8/2/202420.91 USD
8/1/202421.65 USD
7/31/202421.86 USD
7/30/202422.27 USD
7/29/202422.48 USD

Organon & Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Organon &, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Organon & from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Organon &’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Organon &. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Organon &’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Organon &’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Organon &’s growth potential.

Organon & Revenue, EBIT and net profit per share

DateOrganon & RevenueOrganon & EBITOrganon & Net Income
2029e6.25 B USD0 USD1.08 B USD
2028e6.25 B USD1.87 B USD1.06 B USD
2027e6.27 B USD1.89 B USD1.06 B USD
2026e6.54 B USD2.01 B USD1.17 B USD
2025e6.51 B USD1.96 B USD1.17 B USD
2024e6.45 B USD1.9 B USD1.13 B USD
20236.26 B USD1.31 B USD1.02 B USD
20226.17 B USD1.74 B USD917 M USD
20216.3 B USD1.88 B USD1.35 B USD
20206.53 B USD2.86 B USD2.16 B USD
20197.78 B USD3.85 B USD3.22 B USD
20189.78 B USD2.89 B USD2.15 B USD
201710.5 B USD3.26 B USD1.8 B USD

Organon & Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (B USD)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (B USD)EBIT (B USD)EBIT MARGIN (%)NET INCOME (B USD)NET INCOME GROWTH (%)DIV. (USD)DIV. GROWTH (%)SHARES (M)DOCUMENTS
20172018201920202021202220232024e2025e2026e2027e2028e2029e
10.59.787.786.536.36.176.266.456.516.546.276.256.25
--6.89-20.46-16.01-3.49-2.061.442.910.960.49-4.16-0.24-
55.6552.0070.7667.5662.3363.6559.84------
5.845.085.54.413.933.933.75000000
3.262.893.852.861.881.741.311.91.962.011.891.870
31.0529.5949.4743.7229.8428.1820.9529.4830.0930.6930.2229.93-
1.82.153.222.161.350.921.021.131.171.171.061.061.08
-19.5449.47-32.88-37.45-32.1211.5610.563.63-0.26-8.98-1.22
-------------
-------------
253253253253254255256.27000000
-------------
Details

Keystats

ⓘ

Revenue and Growth

The Organon & Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Organon & is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (M USD)RECEIVABLES (B USD)OTHER REC. (M USD)INVENTORIES (B USD)OTHER CURRENT LIAB. (B USD)CURRENT ASSETS (B USD)TANGIBLE ASSETS (B USD)LONG-T. INVEST. (M USD)LONG-T. REC. (M USD)INTANGIBLE ASSETS (M USD)GOODWILL (B USD)OTHER NON-CURRENT ASSETS (B USD)NON-CURRENT ASSETS (B USD)TOTAL ASSETS (B USD)LIABILITIESCOMMON STOCK (M USD)ADDITIONAL PAID-IN CAPITAL (M USD)RETAINED EARNINGS (M USD)OTHER EQUITY (M USD)UNREAL. GAINS/LOSSES (B USD)EQUITY (B USD)LIABILITIES (B USD)PROVISIONS (B USD)OTHER SHORT-TERM LIAB. (M USD)SHORT-TERM DEBTS (B USD)LONG-TERM DEBT PORTION (M USD)SHORT-TERM REC. (B USD)LONG-T. LIAB. (B USD)DEFERRED TAXES (M USD)OTHER LIAB. (B USD)LONG-T. LIABILITIES (B USD)DEBT (B USD)TOTAL CAPITAL (B USD)
201820192020202120222023
24431912737706693
1.491.471.041.381.481.74
0187315115110113
0.991.070.910.9211.32
0.990.91.290.610.640.64
3.713.963.573.763.934.51
0.650.761.021.21.231.36
000000
000000
812569503651649533
4.64.64.64.64.64.6
0.710.660.420.460.541.06
6.786.596.546.927.027.55
10.4910.5510.1110.6810.9612.06
000333
0000025
000-998-331443
-908-914-622-513-564-541
7.267.956.11000
6.357.045.49-1.51-0.89-0.07
0.290.260.261.381.131.31
0.820.810.661.021.191.39
437276416185184206
001.34000
000989
1.551.342.672.62.512.92
0.030.0709.138.918.75
14913912841947
2.421.961.820.460.410.41
2.62.171.959.599.349.21
4.153.514.6212.1911.8512.13
10.4910.5510.1110.6810.9612.06
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of Organon & provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Organon &'s financial health and stability.

Assets

Organon &'s assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Organon & must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Organon & after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Organon &'s financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (B USD)DEPRECIATION (B USD)DEFERRED TAXES (M USD)CHANGES IN WORKING CAPITAL (M USD)NON-CASH ITEM (B USD)PAID INTEREST (M USD)PAID TAXES (M USD)NET CASH FLOW FROM OPERATING ACTIVITIES (B USD)CAPITAL EXPENDITURES (M USD)CASH FLOW FROM INVESTING ACTIVITIES (M USD)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M USD)INTEREST INCOME AND EXPENSES (M USD)NET DEBT CHANGE (B USD)NET CHANGE IN EQUITY (M USD)CASH FLOW FROM FINANCING ACTIVITIES (M USD)CASH FLOW FROM OTHER FINANCING ACTIVITIES (USD)TOTAL DIVIDENDS PAID (M USD)NET CHANGE IN CASH FLOW (M USD)FREE CASH FLOW (M USD)SHARE-BASED COMPENSATION (M USD)
2017201820192020202120222023
1.82.153.312.261.350.921.02
1.971.670.330.140.20.210.24
-1,0453712-32-288-18-485
-1,435-174-672-117702-452-155
2.130.05-0.17-0.020.560.270.28
00000379495
00000214135
3.423.692.772.192.460.860.8
-86-101-92-255-296-303-259
-56-69-102-258-481-420-260
3032-10-3-185-117-1
0000000
-00.0601.517.73-0.11-0.26
0000000
-3,372-4,164-2,621-2,175-1,333-433-569
-3,368.00-4,223.00-2,621.00-3,687.00-8,916.00-35.00-17.00
0000-145-290-294
-45-52775-249667-31-13
3,3333,5862,6751,9322,162555540
0000000

Organon & stock margins

The Organon & margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Organon &. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Organon &.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Organon &'s sales revenue. A higher gross margin percentage indicates that the Organon & retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Organon &'s earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Organon &'s total revenue generated. When comparing the revenue margin year over year, investors can gauge the Organon &'s growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Organon &. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Organon &'s financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Organon & Margin History

Organon & Gross marginOrganon & Profit marginOrganon & EBIT marginOrganon & Profit margin
2029e59.84 %0 %17.24 %
2028e59.84 %29.93 %17.03 %
2027e59.84 %30.22 %16.99 %
2026e59.84 %30.69 %17.88 %
2025e59.84 %30.09 %18.02 %
2024e59.84 %29.48 %17.55 %
202359.84 %20.95 %16.33 %
202263.65 %28.18 %14.85 %
202162.33 %29.84 %21.43 %
202067.56 %43.72 %33.07 %
201970.76 %49.47 %41.38 %
201852 %29.59 %22.02 %
201755.65 %31.05 %17.15 %

Organon & Stock Sales Revenue, EBIT, Earnings per Share

The Organon & earnings per share therefore indicates how much revenue Organon & has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Organon & earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Organon &'s earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Organon &’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Organon &'s prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Organon & Revenue, EBIT and net profit per share

DateOrganon & Sales per ShareOrganon & EBIT per shareOrganon & Earnings per Share
2029e24.31 USD0 USD4.19 USD
2028e24.31 USD0 USD4.14 USD
2027e24.37 USD0 USD4.14 USD
2026e25.43 USD0 USD4.55 USD
2025e25.3 USD0 USD4.56 USD
2024e25.06 USD0 USD4.4 USD
202324.44 USD5.12 USD3.99 USD
202224.21 USD6.82 USD3.6 USD
202124.82 USD7.41 USD5.32 USD
202025.82 USD11.29 USD8.54 USD
201930.74 USD15.21 USD12.72 USD
201838.64 USD11.43 USD8.51 USD
201741.5 USD12.89 USD7.12 USD

Organon & business model

Organon & is one of the most popular companies on Eulerpool.com.

Organon & Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

Organon & historical P/E ratio, EBIT, and P/S ratio.

Organon & shares outstanding

The number of shares was Organon & in 2023 — This indicates how many shares 256.27 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Organon & earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Organon &'s earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Organon &’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Organon &'s prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Organon & dividend history and estimates

In 2023, Organon & paid a dividend amounting to 1.12 USD. Dividend means that Organon & distributes a portion of its profits to its owners.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Dividend
Dividend (Estimate)
Details

Dividend

ⓘ

Dividend Overview

The dividend per year chart for Organon & provides a comprehensive view of the annual dividends distributed to shareholders. Analyze the trend to understand the consistency and growth in dividend payouts over the years.

Interpretation and Use

A consistent or increasing trend in dividends can indicate the company's profitability and financial health. Investors can use this data to identify Organon &’s potential for long-term investment and income generation through dividends.

Investment Strategy

Incorporate the dividend data in evaluating Organon &'s overall performance. A thorough analysis, considering other financial aspects, will help in making informed investment decisions for optimal capital growth and income generation.

Organon & Dividend History

DateOrganon & Dividend
2029e0.23 USD
2028e0.23 USD
2027e0.23 USD
2026e0.22 USD
2025e0.25 USD
2024e0.21 USD
20231.12 USD
20221.12 USD
20210.56 USD

Organon & dividend payout ratio

In 2023, Organon & had a payout ratio of 20.87%. The payout ratio indicates the percentage of the company's profits that Organon & distributes as dividends.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Payout ratio
Details

Payout ratio

ⓘ

What is Yearly Payout Ratio?

The yearly payout ratio for Organon & represents the proportion of earnings paid out as dividends to shareholders. It is an indicator of the company's financial health and stability, illustrating how much profit is being returned to investors versus being reinvested back into the company.

How to Interpret the Data

A lower payout ratio for Organon & could mean that the company is reinvesting more into its growth, whereas a higher ratio indicates more earnings are being distributed as dividends. Investors seeking regular income might prefer companies with a higher payout ratio, while those looking for growth may opt for companies with a lower ratio.

Using the Data for Investments

Evaluate Organon &'s payout ratio in conjunction with other financial metrics and performance indicators. A sustainable payout ratio, coupled with strong financial health, can indicate a reliable dividend payout. However, a very high ratio might suggest the company is not sufficiently reinvesting in its future growth.

Organon & Payout Ratio History

DateOrganon & Payout ratio
2029e22.44 %
2028e22.91 %
2027e22.4 %
2026e22.02 %
2025e24.31 %
2024e20.87 %
202320.87 %
202231.2 %
202110.55 %
202020.87 %
201920.87 %
201820.87 %
201720.87 %
Unfortunately, there are currently no price targets and forecasts available for Organon &.

Organon & latest earnings and earnings surprises

DateEPS EstimateEPS ActualQuarterly report
6/30/20241.09 USD1.12 USD (3.1 %)2024 Q2
3/31/20240.98 USD1.22 USD (24.44 %)2024 Q1
12/31/20230.84 USD0.88 USD (4.97 %)2023 Q4
9/30/20231.07 USD0.87 USD (-18.47 %)2023 Q3
6/30/20231.02 USD1.31 USD (28.85 %)2023 Q2
3/31/20231.17 USD1.08 USD (-7.82 %)2023 Q1
12/31/20220.91 USD0.81 USD (-10.72 %)2022 Q4
9/30/20221.1 USD1.32 USD (19.53 %)2022 Q3
6/30/20221.17 USD1.25 USD (7 %)2022 Q2
3/31/20221.31 USD1.65 USD (25.83 %)2022 Q1
1
2

Eulerpool ESG Scorecard© for the Organon & stock

Eulerpool World ESG Rating (EESG©)

71/ 100

🌱 Environment

66

👫 Social

99

🏛️ Governance

49

Environment

Scope 1 - Direct Emissions
24,981
Scope 2 - Indirect emissions from purchased energy
32,918
Scope 3 - Indirect emissions within the value chain
—
Total CO₂ emissions
57,899
CO₂ reduction strategy
✅
Coal energy
❌
Nuclear power
❌
Animal experiments
✅
Fur & Leather
—
Pesticides
—
Palm Oil
—
Tobacco
❌
Genetically modified organisms
❌
Climate concept
—
Sustainable forestry
—
Recycling regulations
✅
Environmentally friendly packaging
❌
Hazardous substances
✅
Fuel consumption and efficiency
❌
Water consumption and efficiency
✅

Social

Percentage of female employees50
Percentage of women in management—
Percentage of Asian employees18
Share of Asian management—
Percentage of Hispanic/Latino employees6
Hispano/Latino Management share—
Percentage of Black employees9
Black Management Share—
Percentage of white employees67
White Management Share69
Adult content❌
Alcohol❌
Weapons—
Firearms
❌
Gambling❌
Military contracts❌
Human rights concept✅
Privacy concept—
Occupational health and safety✅
Catholic❌

Governance (Corporate Governance)

Environmental reporting✅
Stakeholder Engagement❌
Call Back Policies❌
Antitrust law❌

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

Organon & list of shareholders

%
Name
Stocks
Change
Date
3.91 % MFS Investment Management10,055,750888,74712/31/2023
3.67 % State Street Global Advisors (US)9,442,763-4,280,83012/31/2023
12.11 % BlackRock Institutional Trust Company, N.A.31,148,63418,406,50612/31/2023
11.85 % The Vanguard Group, Inc.30,484,176-860,82912/31/2023
1.82 % Sound Shore Management, Inc.4,675,1371,216,52212/31/2023
1.64 % Citadel Advisors LLC4,210,0962,347,86912/31/2023
1.52 % Geode Capital Management, L.L.C.3,904,165-1,820,06912/31/2023
1.39 % Slate Path Capital LP3,580,7863,580,78612/31/2023
1.30 % LSV Asset Management3,349,579317,72712/31/2023
1.29 % Mellon Investments Corporation3,325,1231,402,23812/31/2023
1
2
3
4
5
...
10

Organon & Executives and Management Board

Mr. Kevin Ali63
Organon & Chief Executive Officer, Director (since 2021)
Compensation 14.95 M USD
Mr. Matthew Walsh56
Organon & Chief Financial Officer, Executive Vice President
Compensation 5.81 M USD
Dr. Sandra Milligan59
Organon & Executive Vice President, Head of Research and Development
Compensation 4.66 M USD
Ms. Susanne Fiedler55
Organon & Executive Vice President, Chief Commercial Officer
Compensation 3.96 M USD
Mr. Joseph Morrissey58
Organon & Executive Vice President, Head of Manufacturing and Supply
Compensation 3.55 M USD
1
2
3
4
...
5

Most common questions regarding Organon &

What is the P/E ratio of Organon & 2024?

The Organon & P/E ratio is 5.07.

What is the P/S ratio of Organon & 2024?

The Organon & P/S ratio is 0.89.

What is the AlleAktien quality score of Organon &?

The AlleAktien quality score for Organon & is 1/10.

What is the revenue of Organon & 2024?

The expected Organon & revenue is 6.45 B USD.

How high is the profit of Organon & 2024?

The expected Organon & profit is 1.13 B USD.

What is the business model of Organon &

No history available for Organon &.

What is the Organon & dividend?

Organon & pays a dividend of 1.12 USD distributed over payouts per year.

How often does Organon & pay dividends?

The dividend cannot currently be calculated for Organon & or the company does not pay out a dividend.

What is the Organon & ISIN?

The ISIN of Organon & is US68622V1061.

What is the Organon & WKN?

The WKN of Organon & is A3CPKP.

What is the Organon & ticker?

The ticker of Organon & is OGN.

How much dividend does Organon & pay?

Over the past 12 months, Organon & paid a dividend of 1.12 USD . This corresponds to a dividend yield of about 5.01 %. For the coming 12 months, Organon & is expected to pay a dividend of 0.25 USD.

What is the dividend yield of Organon &?

The current dividend yield of Organon & is 5.01 %.

When does Organon & pay dividends?

Organon & pays a quarterly dividend. This is distributed in the months of December, March, June, September.

How secure is the dividend of Organon &?

Organon & paid dividends every year for the past 9 years.

What is the dividend of Organon &?

For the upcoming 12 months, dividends amounting to 0.25 USD are expected. This corresponds to a dividend yield of 1.11 %.

In which sector is Organon & located?

Organon & is assigned to the 'Health' sector.

Wann musste ich die Aktien von Organon & kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Organon & from 9/12/2024 amounting to 0.28 USD, you needed to have the stock in your portfolio before the ex-date on 8/16/2024.

When did Organon & pay the last dividend?

The last dividend was paid out on 9/12/2024.

What was the dividend of Organon & in the year 2023?

In the year 2023, Organon & distributed 1.12 USD as dividends.

In which currency does Organon & pay out the dividend?

The dividends of Organon & are distributed in USD.

All fundamentals about Organon &

Our stock analysis for Organon & Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Organon & Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.